Steven D. Reich
Chief Tech/Sci/R&D Officer at ARTELO BIOSCIENCES, INC.
Profile
Steven D.
Reich is currently the Chief Medical Officer at Artelo Biosciences, Inc. and holds the position of Vice President-Clinical Development at Actuate Therapeutics, Inc. Previously, he served as the Chief Executive & Medical Officer at Anaborex, Inc. Dr. Reich obtained his graduate and doctorate degrees from the University of Medicine & Dentistry of New Jersey.
Steven D. Reich active positions
| Companies | Position | Start |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2018-03-31 |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Chief Tech/Sci/R&D Officer | - |
Former positions of Steven D. Reich
| Companies | Position | End |
|---|---|---|
Anaborex, Inc.
 Anaborex, Inc. Medical/Nursing ServicesHealth Services Anaborex, Inc. provides clinical research services for metabolic diseases. The company develops drugs for the treatment of cancer related wasting syndrome. It was founded in 2005 by Alan Saven and Jorge Nieva and is located in La Jolla, CA | President | 2012-12-30 |
Training of Steven D. Reich
| University of Medicine & Dentistry of New Jersey | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ARTELO BIOSCIENCES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Anaborex, Inc.
Anaborex, Inc. Medical/Nursing ServicesHealth Services Anaborex, Inc. provides clinical research services for metabolic diseases. The company develops drugs for the treatment of cancer related wasting syndrome. It was founded in 2005 by Alan Saven and Jorge Nieva and is located in La Jolla, CA | Health Services |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Health Technology |
- Stock Market
- Insiders
- Steven D. Reich
